| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tumor Biology |
The Lombardi Cancer Research Center, Georgetown University School of Medicine, Washington, DC 20007 [C. R. J., J. B., T. C., S. W. B.]; Human Genome Sciences, Inc., Rockville, Maryland 20850 [D. S. B., M. C., P. E. Y.]; and GenVec, Rockville, Maryland 20852 [C. R. K.]
A second adenomatous polyposis coli (APC)-like gene, APC2/APCL, was recently described and localized to chromosome 19. We have fine mapped APC2 to a small region of chromosome 19p13.3 containing markers D19S883 and WI-19632, a region commonly lost in a variety of cancers, particularly ovarian cancer. Interphase fluorescence in situ hybridization analysis revealed an APC2 allelic imbalance in 19 of 20 ovarian cancers screened and indicates that APC2 could be a potential tumor suppressor gene in ovarian cancer. When overexpressed in SKOV3 ovarian cancer cells, which express low levels of APC2, exogenous APC2 localized to the Golgi apparatus, actin-containing structures, and occasionally to microtubules. Antibodies against the NH2 terminus of human APC2 show that endogenous APC2 is diffusely distributed in the cytoplasm and colocalizes with both the Golgi apparatus and actin filaments. APC2 remained associated with actin filaments after treatment with the actin-disrupting agent, cytochalasin D. These results suggest that APC2 is involved in actin-associated events and could influence cell motility or adhesion through interaction with actin filaments, as well as functioning independently or in cooperation with APC to down-regulate ß-catenin signaling.
This article has been cited by other articles:
![]() |
P. Alberici, E. de Pater, J. Cardoso, M. Bevelander, L. Molenaar, J. Jonkers, and R. Fodde Aneuploidy Arises at Early Stages of Apc-Driven Intestinal Tumorigenesis and Pinpoints Conserved Chromosomal Loci of Allelic Imbalance between Mouse and Human Am. J. Pathol., January 1, 2007; 170(1): 377 - 387. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zupkovitz, J. Tischler, M. Posch, I. Sadzak, K. Ramsauer, G. Egger, R. Grausenburger, N. Schweifer, S. Chiocca, T. Decker, et al. Negative and Positive Regulation of Gene Expression by Mouse Histone Deacetylase 1 Mol. Cell. Biol., November 1, 2006; 26(21): 7913 - 7928. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Lipton, O M Sieber, H J W Thomas, S V Hodgson, I P M Tomlinson, and K Woodford-Richens Germline mutations in the TGF-{beta} and Wnt signalling pathways are a rare cause of the "multiple" adenoma phenotype J. Med. Genet., April 1, 2003; 40(4): e35 - 35. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |